Self-reported medication adherence tools in cardiovascular disease: protocol for a systematic review of measurement

Henok G Tegegn1, Edouard Tursan D'Espaignet, Stuart Wark

  • 11School of Rural Medicine, University of New England, Armidale, Australia 2Department of Clinical Pharmacy, School of Pharmacy, University of Gondar, Gondar, Ethiopia 3School of Medicine and Public Health, University of Newcastle, Newcastle, Australia.

JBI Evidence Synthesis
|August 20, 2020
PubMed

Insights

This review identifies reliable self-reported tools to measure medication adherence in adults with cardiovascular disease. Accurate measurement aids in managing chronic conditions and improving patient health outcomes.

Area of Science:

  • Cardiology
  • Pharmacology
  • Health Outcomes Research

Background:

  • Medication adherence is crucial for managing cardiovascular disease (CVD).
  • Poor adherence negatively impacts prognosis and increases mortality risk.
  • Reliable measurement tools are needed to identify non-adherence early.

Purpose of the Study:

  • To identify high-quality, self-reported medication adherence tools for adults with CVD.
  • To support improved health outcomes through better adherence measurement.

Main Methods:

  • Systematic review of studies on self-reported adherence tools for CVD patients.
  • Inclusion of adults (18+) with CVD, measuring initiation, implementation, or discontinuation.
  • Searched multiple databases (PubMed, MEDLINE, etc.) across all languages and dates.

Main Results:

  • Data synthesis focused on the quality of methods and measurement properties of adherence tools.
  • Extensive database searches were conducted to ensure comprehensive identification of relevant studies.

Conclusions:

  • Validated self-reported tools are essential for assessing medication adherence in cardiovascular patients.
  • Accurate adherence measurement can guide interventions to improve clinical outcomes.
Abstract

Related Concept Videos

Assessment of the Cardiovascular System I: Subjective Data01:23

Assessment of the Cardiovascular System I: Subjective Data

A thorough health history and physical assessment are essential for identifying cardiovascular disease (CVD) symptoms and distinguishing them from other health issues.
Initial Enquiry
Ask the patient about their primary concern and thoroughly explore all reported symptoms.
Medical History
Investigate past illnesses affecting the cardiovascular system, such as angina, anemia, rheumatic fever, congenital heart disease, stroke, thrombophlebitis, dysrhythmias, varicosities
Inquire about symptoms...
655
Measurement of Bioavailability: Pharmacodynamic Methods01:20

Measurement of Bioavailability: Pharmacodynamic Methods

Pharmacodynamic methods provide insights into a drug's effects on physiological processes over time and play a crucial role in understanding bioavailability and therapeutic efficacy. These methods can be broadly classified into acute pharmacological and therapeutic response approaches, each with distinct mechanisms and applications.The acute pharmacological response method directly correlates a drug's physiological effects, such as ECG or pupil diameter changes, to its time course in the body.
115
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
246
Cardiovascular Drugs: Classification based on Therapeutic Indications01:18

Cardiovascular Drugs: Classification based on Therapeutic Indications

Cardiovascular diseases, encompassing a range of conditions, can significantly affect the heart's operations and the overall circulatory system. These conditions impair the heart's ability to pump blood, leading to a deficit in oxygen supply to crucial organs. Anomalies in the heart's electrical system, known as arrhythmias, can cause heartbeats to accelerate or slow down. Usually, heart rates increase during physical activity and decrease while resting or sleeping. However,...
3.8K
Assessment of the Gastrointestinal System I: Subjective Data01:17

Assessment of the Gastrointestinal System I: Subjective Data

Assessing the gastrointestinal (GI) system is a complex process that begins with collecting subjective data. This data, collected through patient interviews, provides crucial insights into the patient's health history, perception patterns, and lifestyle habits, all contributing significantly to GI health.
Health History
The initial step in assessing the GI system is obtaining a comprehensive health history. This includes inquiring about the patient's history or presence of problems...
528
Rheumatic Heart Disease III: Medical Management01:21

Rheumatic Heart Disease III: Medical Management

Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...
166